Pala A - Search Results

1

L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide.

Korbonits M, Trainer PJ, Fanciulli G, Oliva O, Pala A, Dettori A, Besser M, Delitala G, Grossman AB. Korbonits M, et al. Among authors: pala a. Eur J Endocrinol. 1996 Nov;135(5):543-7. doi: 10.1530/eje.0.1350543. Eur J Endocrinol. 1996. PMID: 8980155

2

Effect of exogenous growth hormone administration on endogenous growth hormone secretion induced by a met-enkephalin analog.

Fanciulli G, Oliva O, Tomasi PA, Pala A, Bertoncelli A, Dettori A, Delitala G. Fanciulli G, et al. Among authors: pala a. Eur J Endocrinol. 1996 Jan;134(1):73-6. doi: 10.1530/eje.0.1340073. Eur J Endocrinol. 1996. PMID: 8590960 Clinical Trial.

3

Effect of captopril, an inhibitor of the converting enzyme on naloxone induced secretion of ACTH and LH in man.

Palermo M, Oliva O, Pala A, Delitala G. Palermo M, et al. Among authors: pala a. Horm Metab Res. 1993 Oct;25(10):536-8. doi: 10.1055/s-2007-1002169. Horm Metab Res. 1993. PMID: 8262463

4

Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male.

Tomasi PA, Fanciulli G, Palermo M, Pala A, Demontis MA, Delitala G. Tomasi PA, et al. Among authors: pala a. Horm Metab Res. 1998 Jan;30(1):34-6. doi: 10.1055/s-2007-978827. Horm Metab Res. 1998. PMID: 9503036

5

Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?

Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH. Palermo M, et al. Among authors: pala a. J Endocrinol Invest. 2000 Jul-Aug;23(7):457-62. doi: 10.1007/BF03343755. J Endocrinol Invest. 2000. PMID: 11005270

6

Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess.

Tedde R, Pala A, Melis A, Ulick S. Tedde R, et al. Among authors: pala a. J Endocrinol Invest. 1992 Jun;15(6):471-4. doi: 10.1007/BF03348778. J Endocrinol Invest. 1992. PMID: 1401749

7

Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.

Li A, Tedde R, Krozowski ZS, Pala A, Li KX, Shackleton CH, Mantero F, Palermo M, Stewart PM. Li A, et al. Among authors: pala a. Am J Hum Genet. 1998 Aug;63(2):370-9. doi: 10.1086/301955. Am J Hum Genet. 1998. PMID: 9683587 Free PMC article.

8

Antihypertensive effect of insulin reduction in diabetic-hypertensive patients.

Tedde R, Sechi LA, Marigliano A, Pala A, Scano L. Tedde R, et al. Among authors: pala a. Am J Hypertens. 1989 Mar;2(3 Pt 1):163-70. doi: 10.1093/ajh/2.3.163. Am J Hypertens. 1989. PMID: 2645915

9

Effects of ketanserin on transmembrane sodium transport in erythrocytes.

Sechi LA, Tedde R, Cassisa L, Marigliano A, Uneddu F, Melis A, Pala A. Sechi LA, et al. Among authors: pala a. J Cardiovasc Pharmacol. 1990 Feb;15(2):269-75. doi: 10.1097/00005344-199002000-00014. J Cardiovasc Pharmacol. 1990. PMID: 1689423

10

[Trans-membrane cationic flow and hemodialysis].

Sechi LA, Orecchioni C, Melis A, Pala A, Tedde R. Sechi LA, et al. Among authors: pala a. Boll Soc Ital Biol Sper. 1990 Oct;66(10):1001-8. Boll Soc Ital Biol Sper. 1990. PMID: 1710902 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters